TPD & Induced Proximity Summit Leaderboard
  • Friday, June 19, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 7

Author

Pharma Journalist 8887 posts 0 comments

SK bioscience, Colombia Partner on Vaccine Manufacturing Initiative

May 28, 2026
SK bioscience has signed an agreement with Colombia’s state-owned pharmaceutical company VECOL to support vaccine technology transfer and local manufacturing, marking a significant step…
Read More...

Merz, Kvvit Partner to Develop INBRIJA in Greater China

May 27, 2026
Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. have entered into an exclusive licensing and collaboration agreement to develop and commercialize INBRIJA® (levodopa…
Read More...

Insilico, HLFM Partner on AI Longevity Models

May 27, 2026
Insilico Medicine and Human Life Foundation Models, Inc. (HLFM) have entered into a multi-million-dollar collaboration to develop what the companies describe as the biotechnology…
Read More...

FDA Grants Fast Track to Elunetirom for Bipolar Depression

May 27, 2026
Autobahn Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to elunetirom, the company’s lead investigational therapy for the…
Read More...

Lilly Reports Positive Early Results for VERVE-102

May 27, 2026
Eli Lilly and Company reported positive interim results from the Phase 1b Heart-2 clinical study of VERVE-102, an investigational gene-editing therapy designed to lower low-density…
Read More...

EMA Panel Backs BRAFTOVI for Metastatic Colorectal Cancer

May 26, 2026
Pierre Fabre Laboratories announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of…
Read More...

Advancing Respiratory Medicine Following ATS – What Now?

May 26, 2026
The energy coming out of this year’s ATS meeting was unmistakable: respiratory medicine is entering a new era of scientific ambition, cross‑industry collaboration, and patient‑centred…
Read More...

FDA Approves First Hepatitis Delta Treatment in United States

May 25, 2026
Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living…
Read More...

CHMP Supports MAVIRET Approval for Acute Hepatitis C

May 25, 2026
AbbVie announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of MAVIRET®…
Read More...

FDA Approves Datroway for Advanced Triple-Negative Breast Cancer

May 25, 2026
AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan) for adults with unresectable or metastatic…
Read More...
Prev Next
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Voro and Alloy Partner on Safer Cancer Immunotherapies
  • uniQure Reports Early Promise for Epilepsy Gene Therapy
  • Boltz and Takeda Expand AI-Powered Drug Discovery Efforts
  • SK Pharmteco Partners With OTXL for Rare Disease Therapies
  • Next-Generation GLP-1 Therapies Are Reshaping the Future of Obesity Treatment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.